Literature DB >> 11093690

Progressive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy.

Y Nanke1, H Akama, H Yamanaka, M Hara, N Kamatani.   

Abstract

We describe an extraordinary patient with overlap syndrome (systemic lupus erythematosus, systemic sclerosis, and rheumatoid arthritis) having positive autoantibodies against Sm, double stranded DNA, DNA topoisomerase I, and centromere, together with rheumatoid factor. The patient had multiple organ involvement resulting from thrombotic microangiopathy that mimicked so-called normotensive scleroderma renal crisis, and died mainly of massive pulmonary hemorrhage caused by thrombotic thrombocytopenic purpura. The clinical presentations of the case support the concept of strong associations between disease-specific autoantibodies and clinical features.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093690     DOI: 10.1097/00000441-200011000-00010

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Acute kidney injury in patients with systemic sclerosis participating in hematopoietic cell transplantation trials in the United States.

Authors:  Chitra Hosing; Richard Nash; Peter McSweeney; Shin Mineishi; James Seibold; Linda M Griffith; Howard Shulman; Ellen Goldmuntz; Maureen Mayes; Chirag R Parikh; Leslie Crofford; Lynette Keyes-Elstein; Daniel Furst; Virginia Steen; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-11       Impact factor: 5.742

Review 2.  Systemic sclerosis complicated with renal thrombotic microangiopathy: a case report and literature review.

Authors:  Weiwei Kong; Yaomin Wang; Huiping Wang; Qin Zhou; Jianghua Chen; Fei Han
Journal:  BMC Nephrol       Date:  2022-01-10       Impact factor: 2.388

Review 3.  Scleroderma-associated thrombotic microangiopathy in overlap syndrome of systemic sclerosis and systemic lupus erythematosus: A case report and literature review.

Authors:  Xiaodong Xie; Guoqin Wang; Hong Cheng; Lijun Sun; Hongrui Dong
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.